Clinical and Pharmacokinetic Data Support Once-Daily Low-Dose Boosted Saquinavir (1,200 Milligrams Saquinavir with 100 Milligrams Ritonavir) in Treatment-Naive or Limited Protease Inhibitor-Experienced Human Immunodeficiency Virus-Infected Patients

類似資料

• Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected Patients
  著者:: Ford, Jennifer, 等
  出版事項: (2004)
• Pharmacokinetics of Darunavir at 900 Milligrams and Ritonavir at 100 Milligrams Once Daily when Coadministered with Efavirenz at 600 Milligrams Once Daily in Healthy Volunteers
  著者:: Soon, Gaik H., 等
  出版事項: (2010)
• Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial
  著者:: Geretti, Anna Maria, 等
  出版事項: (2015)
• Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
  著者:: Kaeser, Benoite, 等
  出版事項: (2009)
• Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients
  著者:: Montaner, Julio S.G., 等
  出版事項: (2006)